The first and only Compulsory License has been provided to Natco Pharmaceuticals to produce a generic medicine. The medicine named as sorafenib tosylate (Nexavar) is a drug for

• A. Blood cancer
• B. Kidney cancer
• C. Breast cancer
• D. Stomach cancer